Immunocine Cancer Center has appointed Vita S. Salsman as Executive Director to enhance its operational strategy and clinical programs. Salsman, a veteran in cell therapy with over two decades of experience in cancer immunotherapy, will lead the organization’s ongoing advancements in personalized cancer care.
Who to call at Immunocine Cancer Center, and when
A new leader at Immunocine Cancer Center brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Immunocine Cancer Center raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Immunocine Cancer Center, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Immunocine Cancer Center. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Immunocine Cancer Center
Location
Houston, Texas, United States
About
Immunocine Cancer Center is advancing a personalized approach to cancer treatment through its proprietary dendritic cell immunotherapy platform. The organization focuses on innovative therapies in cancer immunotherapy and translational medicine. With a commitment to scientific excellence, Immunocine aims to make a meaningful difference in the lives of cancer patients and their families.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Immunocine Cancer Center changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
HoustonBiotechnologyHealth CareMedicalTherapeutics